Barkat Health & Pharmaceutical Group
with over 20 subsidiary companies, was established in 2010 (1389 AH) under the name “Tadbir Advanced Pharmaceutical Technologies Company,” based on analysis and future foresight of Iran’s pharmaceutical industry, with the goal of responding to societal needs. As a knowledge-based economic entity, we have chosen to focus our approach on health products.
Our activities are based on moving toward the realization of Iran’s Vision 2025 and aligning with the National Comprehensive Scientific Map, in line with social responsibility and valuing human principles. One of the group’s key objectives is to help promote social justice and improve access to new health products for the underprivileged by producing medications at more affordable prices. The group’s overarching strategy also includes entering advanced pharmaceutical fields such as biotechnology, drug delivery technologies like nanotechnology, slow-release drugs, and new health technology areas, along with the development of the cellular and molecular industry, including cell therapy, gene therapy, immunotherapy, and tissue engineering technologies.
